
Biomednewsbreaks - Targeting The Unmet: Soligenix Inc. (NASDAQ: SNGX) Building Portfolio For Rare Conditions
(MENAFN- Investor Brand Network) According to a recent article,“Behçet's disease is rare, with prevalence estimates varying from 0.12 to 7.5 per 100,000 in the United States and Europe... Behçet's disease is believed to be an autoimmune illness …